Davidson B - Search Results

1

Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas.

Hardell E, Josefson S, Ghaderi M, Skeie-Jensen T, Westbom-Fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW. Hardell E, et al. Among authors: davidson b. Am J Surg Pathol. 2017 Sep;41(9):1231-1237. doi: 10.1097/PAS.0000000000000894. Am J Surg Pathol. 2017. PMID: 28622181

2

D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.

Bassarova AV, Nesland JM, Davidson B. Bassarova AV, et al. Among authors: davidson b. Am J Surg Pathol. 2006 Jul;30(7):878-82. doi: 10.1097/01.pas.0000208280.29291.34. Am J Surg Pathol. 2006. PMID: 16819331

3

Tenascin-X is a novel diagnostic marker of malignant mesothelioma.

Yuan Y, Nymoen DA, Stavnes HT, Rosnes AK, Bjørang O, Wu C, Nesland JM, Davidson B. Yuan Y, et al. Among authors: davidson b. Am J Surg Pathol. 2009 Nov;33(11):1673-82. doi: 10.1097/PAS.0b013e3181b6bde3. Am J Surg Pathol. 2009. PMID: 19738457 Free PMC article.

4

Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.

Brenne K, Nymoen DA, Hetland TE, Trope' CG, Davidson B. Brenne K, et al. Among authors: davidson b. Hum Pathol. 2012 Apr;43(4):496-505. doi: 10.1016/j.humpath.2011.05.023. Epub 2011 Aug 19. Hum Pathol. 2012. PMID: 21855111

5

Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.

Elstrand MB, Stavnes HT, Tropé CG, Davidson B. Elstrand MB, et al. Among authors: davidson b. Hum Pathol. 2012 Apr;43(4):529-35. doi: 10.1016/j.humpath.2011.05.022. Epub 2011 Aug 23. Hum Pathol. 2012. PMID: 21864883

6

DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.

Pradhan M, Davidson B, Abeler VM, Danielsen HE, Tropé CG, Kristensen GB, Risberg BÅ. Pradhan M, et al. Among authors: davidson b. Virchows Arch. 2012 Sep;461(3):291-8. doi: 10.1007/s00428-012-1275-2. Epub 2012 Jul 24. Virchows Arch. 2012. PMID: 22824999 Free PMC article.

7

Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.

Davidson B, Abeler VM, Hellesylt E, Holth A, Shih IeM, Skeie-Jensen T, Chen L, Yang Y, Wang TL. Davidson B, et al. Gynecol Oncol. 2013 Feb;128(2):349-55. doi: 10.1016/j.ygyno.2012.11.021. Epub 2012 Nov 21. Gynecol Oncol. 2013. PMID: 23178314 Free PMC article.

8

Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion.

Davidson B, Smith Y, Nesland JM, Kærn J, Reich R, Tropè CG. Davidson B, et al. Hum Pathol. 2013 Nov;44(11):2449-60. doi: 10.1016/j.humpath.2013.06.003. Epub 2013 Sep 5. Hum Pathol. 2013. PMID: 24011953

9

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.

Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH. Hoang LN, et al. Among authors: davidson b. Am J Surg Pathol. 2013 Sep;37(9):1421-32. doi: 10.1097/PAS.0b013e31828c63ed. Am J Surg Pathol. 2013. PMID: 24076778

10

APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival.

Tuft Stavnes H, Nymoen DA, Hetland Falkenthal TE, Kærn J, Tropé CG, Davidson B. Tuft Stavnes H, et al. Among authors: davidson b. Am J Clin Pathol. 2014 Jul;142(1):51-7. doi: 10.1309/AJCPD8NBSHXRXQL7. Am J Clin Pathol. 2014. PMID: 24926085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,550 results

Search Page

Filters